Search For "us pharmaceutical company"
Moderna to supply twice as many than planned COVID vaccine doses in 2022
Updated : 4 years, 11 months ago IST
New York [US], April 29 (ANI/Sputnik): US pharmaceutical company Moderna seeks to supply 3 billion vaccine doses against COVID-19 in 2022 instead of 1.4 billion, which is twice as many than planned, according to the company's statement, published on Thursday.
Read More
Spain receives first batch of Moderna COVID-19 vaccine
Updated : 5 years, 2 months ago IST
Madrid [Spain], January 12 (ANI/Sputnik): Spain received on Tuesday the first shipment of the vaccine against COVID-19 developed by the US pharmaceutical company Moderna, national media said.
Read More
Spain to receive 1st batch of Moderna vaccine in 7-10 days: Health Ministe
Updated : 5 years, 2 months ago IST
Madrid [Spain, January 7 (ANI/Sputnik): Spain will receive the first batch of the coronavirus vaccine developed by US pharmaceutical company Moderna in 7-10 days, Spanish Health Minister Salvador Illa said on Thursday.
Read More
Moderna to produce at least 600 million doses of COVID-19 vaccine in 2021
Updated : 5 years, 2 months ago IST
Washington [US], January 5 (ANI/Sputnik): US pharmaceutical company Moderna said it planned to produce at least 600 million doses of its vaccine against COVID-19 in 2021, not 500 million as previously announced.
Read More
Kazakhstan inks COVID-19 vaccine deal with Pfizer, says Health Ministry
Updated : 5 years, 2 months ago IST
Almaty [Kazakhstan], December 28 (ANI/Sputnik): Kazakhstan on Monday signed a deal with US pharmaceutical company Pfizer to begin receiving its vaccine against the coronavirus disease, the health ministry said.
Read More
Moderna says US ordered 100 mln additional doses of coronavirus vaccine
Updated : 5 years, 3 months ago IST
Washington [US], December 12 (ANI/Sputnik): The United States has secured 100 million more doses of the mRNA coronavirus vaccine by US pharmaceutical company Moderna, the developer said in a press release.
Read More
Eli Lilly pauses COVID-19 treatment trial for Safety Reasons
Updated : 5 years, 5 months ago IST
Washington [US], October 14 (ANI/Sputnik): The US pharmaceutical company Eli Lilly's late-stage trial of its leading monoclonal antibody treatment for the novel coronavirus has been paused by health regulators over potential safety concerns, CNBC reported.
Read More